MAPP BIOPHARMACEUTICAL, INC.

Federal contract awards won by MAPP BIOPHARMACEUTICAL, INC. (UEI M9V9QTHR1H28), 2016–2024 — public record from USAspending.

Showing awards with a value or ceiling of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.

9
awards
1
expiring in 12 months
2
agencies

Category award history

9 category awards to a new vendor (same agency and NAICS code, not this contract's own history) — latest: VERICEL CORPORATION took Department of Health and Human Services 541714 work from MAPP BIOPHARMACEUTICAL, INC. (Jun 30, 2026).

Agencies buying from MAPP BIOPHARMACEUTICAL, INC.

Awards

DEVELOPMENT OF MEDICAL COUNTERMEASURES THROUGH PLANNED CLINICAL TRIALS AND OUTBREAK PREPAREDNESS
Department of Health and Human Services · $5,626,972 · Mar 20, 2024
PROCUREMENT OF THERAPEUTICS FOR EBOLA, SUDAN AND MARBURG VIRUSES
Department of Health and Human Services · $223,292,319 · Sep 30, 2022
BASE YEAR FOR MACV CONTRACT GENERATES MACV IGG2
Department of Defense · $480,000 · Sep 30, 2021
DEVELOPMENT OF A PAN-BOTULINUM NEUROTOXIN MEDICAL COUNTERMEASURE
Department of Health and Human Services · $16,413,163 · Sep 30, 2020
STTR PHASE II
Department of Defense · $1,499,004 · Jul 28, 2020
IGF::OT::IGF
Department of Health and Human Services · $55,836,771 · Sep 25, 2018
IGF::OT::IGF
Department of Health and Human Services · $7,486,451 · Sep 13, 2017
MAPP EAP - IGF::CL::IGF FOR OTHER FUNCTIONSEXPANDED ACCESS PROTOCOL FOR ZMAPP
Department of Health and Human Services · $28,870,288 · Jun 27, 2016